(via Thenewswire.ca)
Coverage is Geared to Matching Investors with Innovations in Healthcare and Finance
Toronto, Canada - CardioComm Solutions, Inc. (TSX-V:EKG) ("CardioComm Solutions" or "the Company"), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, announced that it has contracted Crystal Research Associates, LLC ("Crystal Research"), a New York-based independent equity research firm, to develop an Executive Informational Overview(R) (EIO) and Quarterly Updates. The Crystal Research reports highlight the Company's performance and key accomplishments.
Crystal Research Associates was established in 2003 to fill a market need for communicating innovative companies' stories to a viewership of investors, journalists, and others in the mainstream media seeking to gain a clear and objective understanding of a company's business. Crystal Research's principals, Kraws and Goldfarb, are well known and highly respected on Wall Street and by the international financial media for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side. The engagement with CardioComm Solutions is for one year of coverage and involves cash and common shares of the Company issued to Crystal Research as milestones are completed and in accordance with the TSX Venture Exchange. The EIO(R) and Quarterly Updates will be distributed to investor audiences through the Crystal Research website (www.crystalra.com) and corporate contacts as well as through a variety of social media and other online outlets.
"We are excited to have Crystal Research working with us and expanding our presence in the investment community with respect to increasing the appreciation of our disruptive ECG monitoring technologies, the introduction of our consumer HeartCheck(TM) ECG device, and our market potential," said Etienne Grima, Chief Executive Officer of the Company.
Crystal Research is also a sponsor of the OneMedPlace platform, where CardioComm Solutions' CEO, Etienne Grima, presented in January 2013 to the investor audience in attendance as well as to online technology investors. "The invitation to present at the 6th Annual OneMedForum was a great opportunity and a first step in the 2013 marketing efforts of our Company to promote awareness and adoption of the HeartCheck(TM) products and SMART Monitoring software platform. Our own anticipated Q1 and Q2 announcements coupled with the efforts of the Crystal Research team will add confirmation to the support our products have been receiving," said Simi Grosman, member of the Company's Board of Directors.
About Crystal Research Associates, LLC
Crystal Research Associates, LLC (www.crystalra.com) is an independent research firm that has provided institutional-quality research on small- and mid-cap companies for the past decade. The firm is led by veteran Wall Street sell-side analyst Jeffrey Kraws, who is well known by the international financial media for his years of work on Wall Street as well as for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side. He has been consistently ranked on Wall Street among the Top Ten Analysts for pharmaceutical stock performance in the world for almost two decades as well as ranked as the Number One Stock Picker in the world for pharmaceuticals by Starmine and for estimates from Zacks. Additionally, Mr. Kraws has been 5-Star ranked for top biotechnology stock performance by Starmine and for estimates from Zacks.
Crystal Research Associates' Executive Informational Overview(R) (EIO), is free of investment ratings, target prices, and forward-looking financial models and presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City and West Palm Beach.
About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing, and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.
FOR FURTHER INFORMATION ON CARDIOCOMM SOLUTIONS, PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425
egrima@cardiocommsolutions.com
www.cardiocommsolutions.com
Forward-looking Statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations, and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2013 TheNewswire - All rights reserved.